Premium
Comparison Between Premixed and Compounded Parenteral Nutrition Solutions in Hospitalized Patients Requiring Parenteral Nutrition
Author(s) -
Beattie Colleen,
Allard Johane,
Raman Maitreyi
Publication year - 2016
Publication title -
nutrition in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.725
H-Index - 71
eISSN - 1941-2452
pISSN - 0884-5336
DOI - 10.1177/0884533615621046
Subject(s) - medicine , parenteral nutrition , intensive care medicine
Rationale: Parenteral nutrition (PN) may be provided through compounded or premixed solutions. Objective: To determine the proportion of stable custom‐compounded PN prescriptions that would fit within a 20% deviance of an existing premixed PN solution. Methods: A retrospective study design was used. Inpatients who received PN in non–critical care units in the preceding year were screened for eligibility. Results are reported descriptively as means (95% confidence intervals) and proportions. Results: We reviewed 97 PN prescriptions that met inclusion criteria. Stable hospital PN prescriptions compared with the reference premixed prescription provided 1838 (1777–1898) vs 1843 (1781–1905) kcal/d, P = .43; dextrose, 266 (254–277) vs 225 (216–234) g/d, P < .001; amino acids, 100 (95.9–104) vs 95.2 (91.7–98.7) g/d, P < .001; and lipids, 53.2 (51.3–55.1) vs 76.5 (73.8–79.2) g/d, P < .001. Fifty‐eight of 97 (59.8%) matched for 2 of 3 macronutrients. Hospital compared with premixed lipid was lower 53.6 (43–64.2) g/d vs 75.5 (60.5–90.5) g/d, P < .001. Electrolytes differed between hospital and premixed solutions: sodium, 98.6 (95.0–102) vs 66.9 (64.6–69.9) mmol/L, P < .001; potassium, 93.7 (89.0–98.3) vs 57.4 (55.4–59.4) mmol/L, P < .001; and magnesium, 5.4 (4.8–5.4) vs 7.6 (7.4–7.9) mmol/L. Conclusions: Calories and protein were remarkably similar, but dextrose, lipid, and electrolytes differed between hospital PN and the reference premixed prescription. We believe that there may be a role for premixed solutions in quaternary centers in stable non–critically ill patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom